Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: A randomised, controlled study

European Journal of Anaesthesiology

Volumn 31, Issue 9, 2014, Pages 491-498

  Faraoni, David ^a   Cacheux, Christophe ^b   Van Aelbrouck, Caroline ^b   Ickx, Brigitte E ^b   Barvais, Luc ^b   Levy, Jerrold H ^c  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; PLACEBO; PROTAMINE; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FIBRINOLYSIS; HEART SURGERY; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOELASTOGRAPHY; TREATMENT INDICATION; BLOOD LOSS, SURGICAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MIDDLE AGED; PILOT PROJECTS; PROTAMINES; THROMBELASTOGRAPHY; TRANEXAMIC ACID;

EID: 84927923934     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000051     Document Type: Article

References (24)

1. Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113:1319-1333.
2. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;CD001886.
3. Fiechtner B. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg 2001; 92:1131-1136.
4. Dowd N. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97:390-399.
5. Sharma V, Fan J, Jerath A, et al. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia 2012; 67:1242-1250.
6. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358:2319-2331.
7. Cantraine FR, Coussaert EJ. The first object oriented monitor for intravenous anesthesia. J Clin Monit Comput 2000; 16:3-10.
8. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17:237-246.
9. Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82:383-392.
10. Solomon C, Cadamuro J, Ziegler B, et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51:1695-1706.
11. Ziegler S, Ortu A, Reale C, et al. Fibrinolysis or hypercoagulation during radical prostatectomy? An evaluation of thrombelastographic parameters and standard laboratory tests. Eur J Anaesthesiol 2008; 25:538-543.
12. Iqbal A, Morton C, Kong KL. Fibrinolysis during anaphylaxis, and its spontaneous resolution, as demonstrated by thromboelastography. Br J Anaesth 2010; 105:168-171.
13. Theusinger OM, Wanner GA, Emmert MY, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113:1003-1012.
14. Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100:792-797.
15. Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study. Br J Anaesth 2011; 107:378-387.
16. Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11:307-314.
17. Hunt BJ, Raza I, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients: a reply to a rebuttal. J Thromb Haemost 2013; 11:1437-1438.
18. Faraoni D, Levy JH. Algorithm-based management of bleeding in patients with extracorporeal membrane oxygenation. Crit Care 2013; 17:432.
19. Ozolina A, Strike E, Jaunalksne I, et al. PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass. BMC Anesthesiol 2012; 12:27.
20. Greilich PE, Jessen ME, Satyanarayana N, et al. The effect of epsilonaminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. Anesth Analg 2009; 109:15-24.
21. Bates SM. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 2012; 38:673-682.
22. de Moerloose P, Palareti G, Aguilar C, et al. A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. Thromb Haemost 2008; 100:505-512.
23. Kalavrouziotis D, Voisine P, Mohammadi S, et al. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012; 93:148-154.
24. Koster A, Borgermann J, Zittermann A, et al. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013; 110:34-40.